[Cutaneomucosal herpes in immunocompetent pregnant women].
Genital herpes is a common sexually transmitted disease. In pregnant women, the risk of fetal contamination is high, particularly during the per and peripartum period. Certain prevention strategies have been changed with the advent of new antiviral agents and treatment protocols at the end of pregnancy remain to be evaluated. Based on a review of the literature, we discuss a few of these different questions raised at the French consensus conference on the management of cutaneomucosal herpes in immunocompetent pregnant women (ocular manifestations excluded).
Lecat
M
M
Service de Gynécologie, Hôpital Robert-Debré, 48, boulevard Sérurier, 75935 Paris Cedex 19, France.
D000212:Acyclovir / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002585:Cesarean Section; D005260:Female; D006558:Herpes Genitalis / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D018259:Herpesvirus 1, Human; D018258:Herpesvirus 2, Human; D006801:Humans; D007121:Immunocompetence; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control
D000998:Antiviral Agents; D000212:Acyclovir